Lineage Cell Therapeutics IncNYSE American:LCTX
- LAST PRICE1.1400
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 1.1400
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | LCTX |
|---|---|---|
| 09:32 ET | 4152 | 1.13 |
| 09:34 ET | 164 | 1.145 |
| 09:36 ET | 5000 | 1.1499 |
| 09:38 ET | 5700 | 1.145 |
| 09:39 ET | 871 | 1.145 |
| 09:41 ET | 100 | 1.15 |
| 09:43 ET | 16532 | 1.15 |
| 09:52 ET | 1395 | 1.1574 |
| 09:56 ET | 9786 | 1.16 |
| 09:57 ET | 387 | 1.165 |
| 10:03 ET | 2066 | 1.17 |
| 10:06 ET | 9431 | 1.175 |
| 10:08 ET | 200 | 1.17 |
| 10:10 ET | 314 | 1.175 |
| 10:12 ET | 600 | 1.175 |
| 10:14 ET | 100 | 1.175 |
| 10:15 ET | 1025 | 1.175 |
| 10:17 ET | 3465 | 1.175 |
| 10:19 ET | 100 | 1.175 |
| 10:21 ET | 300 | 1.175 |
| 10:24 ET | 1267 | 1.175 |
| 10:26 ET | 200 | 1.175 |
| 10:28 ET | 6526 | 1.185 |
| 10:32 ET | 100 | 1.185 |
| 10:39 ET | 210 | 1.185 |
| 10:42 ET | 5300 | 1.185 |
| 10:44 ET | 200 | 1.18 |
| 10:46 ET | 2400 | 1.1802 |
| 10:48 ET | 3489 | 1.175 |
| 10:50 ET | 1100 | 1.175 |
| 10:51 ET | 3468 | 1.17 |
| 10:57 ET | 2107 | 1.17 |
| 11:00 ET | 200 | 1.17 |
| 11:02 ET | 690 | 1.17 |
| 11:04 ET | 100 | 1.16 |
| 11:06 ET | 100 | 1.16 |
| 11:08 ET | 100 | 1.16 |
| 11:09 ET | 100 | 1.16 |
| 11:11 ET | 200 | 1.16 |
| 11:13 ET | 366 | 1.165 |
| 11:15 ET | 600 | 1.165 |
| 11:18 ET | 148 | 1.165 |
| 11:20 ET | 657 | 1.1615 |
| 11:22 ET | 100 | 1.16 |
| 11:24 ET | 850 | 1.165 |
| 11:26 ET | 200 | 1.17 |
| 11:29 ET | 300 | 1.165 |
| 11:31 ET | 2064 | 1.165 |
| 11:33 ET | 1000 | 1.1602 |
| 11:36 ET | 100 | 1.1614 |
| 11:38 ET | 100 | 1.165 |
| 11:40 ET | 100 | 1.165 |
| 11:42 ET | 400 | 1.165 |
| 11:45 ET | 498 | 1.16 |
| 11:47 ET | 2556 | 1.166 |
| 11:49 ET | 6087 | 1.165 |
| 11:51 ET | 100 | 1.17 |
| 11:56 ET | 100 | 1.16 |
| 11:58 ET | 100 | 1.165 |
| 12:02 ET | 1000 | 1.16 |
| 12:03 ET | 900 | 1.165 |
| 12:05 ET | 170 | 1.17 |
| 12:14 ET | 30591 | 1.165 |
| 12:16 ET | 8637 | 1.165 |
| 12:18 ET | 3072 | 1.16 |
| 12:20 ET | 3880 | 1.165 |
| 12:21 ET | 240 | 1.16 |
| 12:23 ET | 100 | 1.16 |
| 12:25 ET | 350 | 1.16 |
| 12:32 ET | 500 | 1.17 |
| 12:39 ET | 1948 | 1.16 |
| 12:41 ET | 600 | 1.16 |
| 12:43 ET | 180 | 1.16 |
| 12:45 ET | 300 | 1.165 |
| 12:52 ET | 5728 | 1.165 |
| 12:56 ET | 800 | 1.16 |
| 12:59 ET | 174 | 1.16 |
| 01:01 ET | 100 | 1.165 |
| 01:03 ET | 400 | 1.165 |
| 01:08 ET | 5300 | 1.165 |
| 01:10 ET | 448 | 1.165 |
| 01:12 ET | 100 | 1.165 |
| 01:15 ET | 100 | 1.165 |
| 01:24 ET | 100 | 1.165 |
| 01:26 ET | 100 | 1.17 |
| 01:30 ET | 100 | 1.165 |
| 01:32 ET | 116 | 1.165 |
| 01:33 ET | 870 | 1.165 |
| 01:42 ET | 100 | 1.17 |
| 01:44 ET | 200 | 1.165 |
| 01:46 ET | 200 | 1.165 |
| 01:51 ET | 108 | 1.165 |
| 01:53 ET | 10781 | 1.165 |
| 01:55 ET | 200 | 1.17 |
| 01:57 ET | 580 | 1.16 |
| 02:02 ET | 1100 | 1.165 |
| 02:04 ET | 411 | 1.165 |
| 02:06 ET | 200 | 1.165 |
| 02:11 ET | 120 | 1.165 |
| 02:15 ET | 100 | 1.165 |
| 02:18 ET | 1000 | 1.16 |
| 02:27 ET | 200 | 1.16 |
| 02:31 ET | 204 | 1.165 |
| 02:45 ET | 100 | 1.17 |
| 02:47 ET | 600 | 1.165 |
| 02:51 ET | 200 | 1.167 |
| 02:56 ET | 1156 | 1.165 |
| 03:00 ET | 2000 | 1.1601 |
| 03:02 ET | 2587 | 1.1628 |
| 03:03 ET | 100 | 1.16 |
| 03:07 ET | 220 | 1.165 |
| 03:09 ET | 100 | 1.165 |
| 03:12 ET | 178 | 1.16 |
| 03:16 ET | 200 | 1.165 |
| 03:18 ET | 100 | 1.165 |
| 03:21 ET | 100 | 1.165 |
| 03:23 ET | 200 | 1.165 |
| 03:25 ET | 1100 | 1.165 |
| 03:27 ET | 400 | 1.165 |
| 03:30 ET | 306 | 1.165 |
| 03:32 ET | 100 | 1.165 |
| 03:34 ET | 403 | 1.165 |
| 03:36 ET | 308 | 1.165 |
| 03:38 ET | 489 | 1.165 |
| 03:39 ET | 100 | 1.165 |
| 03:41 ET | 30434 | 1.15 |
| 03:43 ET | 14708 | 1.14 |
| 03:45 ET | 1800 | 1.14 |
| 03:48 ET | 200 | 1.14 |
| 03:50 ET | 4479 | 1.14 |
| 03:52 ET | 2580 | 1.14 |
| 03:54 ET | 5079 | 1.14 |
| 03:56 ET | 950 | 1.14 |
| 03:57 ET | 913 | 1.14 |
| 03:59 ET | 3118 | 1.14 |
Apr 1, 2024
Lineage Announces Appointment of Charlotte Hubbert, Ph.D., as Vice President of Corporate Development, from 8:00AM ET on Monday Apr 01, 2024 by Dow Jones
8:00AM ET on Monday Apr 01, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Lineage Cell Therapeutics Inc | 214.9M | -9.2x | --- |
CervoMed Inc | 207.9M | -38.7x | --- |
Abeona Therapeutics Inc | 201.3M | -1.3x | --- |
Generation Bio Co | 186.8M | -1.7x | --- |
Adverum Biotechnologies Inc | 235.4M | -0.9x | --- |
Merrimack Pharmaceuticals Inc | 214.1M | -178.4x | --- |
Company Information
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs. The Company’s programs are based on its cell-based technology platform and associated development and manufacturing capabilities. From this platform, the Company designs, develops, manufactures, and tests specialized human cells with anatomical and physiological functions. Its neuroscience focused pipeline includes OpRegen, a retinal pigment epithelial cell therapy in phase II a development, for the treatment of geographic atrophy secondary to age-related macular degeneration; OPC1, an oligodendrocyte progenitor cell therapy in phase I/II a development for the treatment of spinal cord injuries; ANP1, an auditory neuronal progenitor cell therapy for the potential treatment of auditory neuropathy; PNC1, a photoreceptor neural cell therapy for the potential treatment of vision loss due to photoreceptor dysfunction or damage; and RND1.
Contact Information
- Headquarters
- 2173 Salk Ave Ste 200CARLSBAD, CA, United States 92008-7354
- Phone
- 510-521-3390
- Fax
- 510-521-3389
Executives
- Non-Executive Independent Chairman of the Board
- Alfred Kingsley
- Chief Executive Officer, Interim Chief Financial Officer, Director
- Brian Culley
- Chief Financial Officer
- Jill Howe
- Senior Vice President - Clinical and Medical Affairs
- Gary Hogge
- General Counsel, Corporate Secretary
- George Samuel
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $214.9M |
|---|---|
Revenue (TTM) | $8.9M |
Shares Outstanding | 188.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.38 |
EPS | $-0.12 |
Book Value | $0.36 |
P/E Ratio | -9.2x |
Price/Sales (TTM) | 24.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -276.50% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
